|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,961.50 GBX | +0.10% |
|
-2.66% | +7.51% |
| 10/07 | GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial | AN |
| 10/07 | GSK, Hansoh's targeted cancer drug hits main survival goal in China trial | RE |
Insider Transaction History
Latest insider transactions for GSK plc
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 22/06 | Buy | Executive/Senior Manager | 9 | 50.74 | 456.66 | 0.0000% | ||
| 08/06 | Buy | Executive/Senior Manager | 9 | 50.64 | 455.76 | 0.0000% | ||
| 22/05 | Buy | Executive/Senior Manager | 9 | 51.38 | 462.42 | 0.0000% | ||
| 15/05 | Buy | Director | 2,301 | 49.67 | 1L | 0.0001% | ||
| 15/05 | Buy | Executive/Senior Manager | 82 | 49.67 | 4.07T | 0.0000% | ||
| 15/05 | Buy | Compliance Officer | 54 | 49.67 | 2.68T | 0.0000% | ||
| 15/05 | Buy | Director | 74 | 49.67 | 3.68T | 0.0000% | ||
| 12/05 | Buy | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Buy | 7 | 18.66 | 130.58 | 0.0000% | |||
| 12/05 | Buy | Executive/Senior Manager | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Free | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Free | Chief Financial Officer | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Buy | Chief Financial Officer | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Free | Executive/Senior Manager | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Free | 7 | 18.66 | 130.58 | 0.0000% | |||
| 12/05 | Buy | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Buy | Company Secretary | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Free | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Free | Compliance Officer | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Free | Company Secretary | 7 | 18.66 | 130.58 | 0.0000% | ||
| 12/05 | Buy | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Free | 6 | 18.66 | 111.93 | 0.0000% | |||
| 12/05 | Buy | 6 | 18.66 | 111.93 | 0.0000% | |||
| 12/05 | Free | Executive/Senior Manager | 6 | 18.66 | 111.93 | 0.0000% | ||
| 12/05 | Buy | Compliance Officer | 7 | 18.66 | 130.58 | 0.0000% | ||
| 07/05 | Buy | Executive/Senior Manager | 9 | 50.50 | 454.5 | 0.0000% | ||
| 01/05 | Free | Head of Human Resources | 35,508 | 19.01 | 7L | 0.0009% | ||
| 29/04 | Buy | Director | 4,000 | 19.63 | 78.52T | 0.0001% | ||
| 28/04 | Fiscal year | Chief Financial Officer | 2,43,880 | - | - | 0.0060% | ||
| 24/04 | Buy | Executive/Senior Manager | 8,572 | 55.70 | 5L | 0.0002% | ||
| 20/04 | Buy | Head of Human Resources | 65 | 58.35 | 3.79T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 270 | 21.67 | 5.85T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 483 | 21.67 | 10.47T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 152 | 58.36 | 8.87T | 0.0000% | ||
| 16/04 | Buy | Chief Financial Officer | 506 | 21.67 | 10.97T | 0.0000% | ||
| 16/04 | Buy | Director | 14 | 58.93 | 825.03 | 0.0000% | ||
| 16/04 | Buy | Chief Technology Officer | 235 | 21.67 | 5.09T | 0.0000% | ||
| 16/04 | Buy | Chief Technology Officer | 215 | 21.67 | 4.66T | 0.0000% | ||
| 16/04 | Buy | Director | 30 | 58.93 | 1.77T | 0.0000% | ||
| 16/04 | Buy | Chief Executive Officer | 316 | 21.67 | 6.85T | 0.0000% | ||
| 16/04 | Buy | Head of Human Resources | 132 | 21.67 | 2.86T | 0.0000% | ||
| 16/04 | Buy | Chief Technology Officer | 159 | 58.36 | 9.28T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 117 | 21.67 | 2.54T | 0.0000% | ||
| 16/04 | Buy | Chief Technology Officer | 515 | 21.67 | 11.16T | 0.0000% | ||
| 16/04 | Buy | Director | 26 | 58.93 | 1.53T | 0.0000% | ||
| 16/04 | Buy | Compliance Officer | 271 | 59.17 | 16.04T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 252 | 21.67 | 5.46T | 0.0000% | ||
| 16/04 | Buy | Director | 96 | 58.93 | 5.66T | 0.0000% | ||
| 16/04 | Buy | Executive/Senior Manager | 401 | 21.67 | 8.69T | 0.0000% | ||
| 16/04 | Buy | Compliance Officer | 109 | 21.67 | 2.36T | 0.0000% | ||
- Stock Market
- Stocks
- GSK Stock
- Company GSK plc
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















